Published in Am J Sports Med on December 16, 1987
Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res (2000) 5.74
An SNP map of human chromosome 22. Nature (2000) 2.99
Failure of chemotherapy to prolong survival in a group of patients with metastatic breast cancer. Lancet (1980) 2.82
A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer. Ann Oncol (1998) 2.18
Prevention of emesis in patients receiving cytotoxic drugs by GR38032F, a selective 5-HT3 receptor antagonist. Lancet (1987) 2.09
Cell production rates in human tissues and tumours and their significance. Part II: clinical data. Eur J Surg Oncol (2000) 1.95
Measurement of in vivo proliferation in human colorectal mucosa using bromodeoxyuridine. Gut (1992) 1.93
Assessment of biochemical tests to screen for metastases in patients with breast cancer. Lancet (1980) 1.88
A new measure of conservatism. Br J Soc Clin Psychol (1968) 1.87
Determination of continuing medical education needs of clinicians from a literature search study, Part I. The study. Bull Med Libr Assoc (1977) 1.83
Survey of treatment of primary breast cancer in Great Britain. Br Med J (Clin Res Ed) (1985) 1.80
Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results. Int J Radiat Oncol Biol Phys (1995) 1.77
Assessment of response of bone metastases to systemic treatment in patients with breast cancer. Cancer (1983) 1.73
The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry. Cytometry (1985) 1.71
Diagnosing breast carcinoma in young women. BMJ (1991) 1.71
Recurrent Cancer of Head and Neck. Br Med J (1962) 1.63
GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON. Br J Cancer (2003) 1.57
Proliferation characteristics of human colorectal carcinomas measured in vivo. Br J Surg (1991) 1.55
Topical calcipotriol treatment in advanced breast cancer. Lancet (1991) 1.53
Efficacy of chromium supplementation in athletes: emphasis on anabolism. Int J Sport Nutr (1992) 1.49
Biochemical markers in human breast cancer. Lancet (1977) 1.48
Carboplatin (Paraplatin; JM8) and etoposide (VP-16) as first-line combination therapy for small-cell lung cancer. J Clin Oncol (1987) 1.47
Prediction of endocrine response in breast cancer by immunocytochemical detection of oestrogen receptor in fine-needle aspirates. Lancet (1987) 1.46
Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer. Br J Cancer (2005) 1.45
Clinical examination, xeromammography, and fine-needle aspiration cytology in diagnosis of breast tumours. Br Med J (1978) 1.44
Physical test for distant metastases in patients with breast cancer. J R Soc Med (1980) 1.42
A prospective analysis of c-myc oncoprotein levels as a prognostic marker in malignant melanoma. J Plast Reconstr Aesthet Surg (2007) 1.41
Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigen. Br J Cancer (1981) 1.39
Prevention of isophosphamide-induced urothelial toxicity with 2-mercaptoethane sulphonate sodium (mesnum) in patients with advanced carcinoma. Lancet (1980) 1.38
Flow cytometric analysis of p53 oncoprotein expression in cutaneous melanoma. Br J Surg (1997) 1.38
Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial. Br Med J (Clin Res Ed) (1981) 1.33
Aminoglutethimide in treatment of metastatic breast carcinoma. Lancet (1978) 1.27
Affective modulation of the startle response in depression: influence of the severity of depression, anhedonia, and anxiety. J Affect Disord (2004) 1.24
Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck. Br J Cancer (1992) 1.24
Bone marrow micrometastases in primary breast cancer: prognostic significance after 6 years' follow-up. Eur J Cancer (1991) 1.23
Prospective randomized trial of tamoxifen vs surgery in elderly patients with breast cancer. Eur J Surg Oncol (1994) 1.19
Prospective randomised trial of tamoxifen versus surgery in elderly patients with breast cancer. Lancet (1988) 1.15
Factors affecting acute skin toxicity in patients having breast irradiation after conservative surgery: a prospective study of treatment practice at the Royal Marsden Hospital. Clin Oncol (R Coll Radiol) (1996) 1.13
A preliminary clinical study of gossypol in advanced human cancer. Cancer Chemother Pharmacol (1992) 1.13
Flow cytometric evaluation of hypoxic cells in solid experimental tumours using fluorescence immunodetection. Br J Cancer (1991) 1.11
The results of radiotherapy for Hodgkins' disease. Br J Cancer (1975) 1.06
Advances in cell kinetics. BMJ (1991) 1.05
The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis. Radiother Oncol (1999) 1.05
A review of factors affecting blood biochemistry in the pig. Br Vet J (1972) 1.04
Combination chemotherapy for thrombocytopenia with bone marrow metastases from breast cancer. Br Med J (1977) 1.03
Treatment of advanced breast cancer in postmenopausal women with 4-hydroxyandrostenedione. Cancer Chemother Pharmacol (1990) 1.00
Bioreductive fluorescent markers for hypoxic cells: a study of 2-nitroimidazoles with 1-substituents containing fluorescent, bridgehead-nitrogen, bicyclic systems. J Med Chem (1992) 1.00
Social and psychological factors in the distribution of STD in male clinic attenders. I Demographic and social factors. Br J Vener Dis (1983) 0.99
Sexual orientation and the 2nd to 4th finger length ratio: evidence for organising effects of sex hormones or developmental instability? Psychoneuroendocrinology (2003) 0.99
Proliferation indices of invasive breast carcinomas after in vivo 5-bromo-2'-deoxyuridine labelling: a flow cytometric study of 75 tumours. Br J Surg (1992) 0.99
A biochemical approach to the staging of human breast cancer. Cancer (1977) 0.98
Effects of three combinations of plyometric and weight training programs on selected physical fitness test items. Percept Mot Skills (1983) 0.98
Comparison of the BOD POD with the four-compartment model in adult females. Med Sci Sports Exerc (2001) 0.96
c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma. Br J Ophthalmol (1999) 0.95
Sweat-gland tumours: a clinical review of cases in one centre over 20 years. Clin Oncol (R Coll Radiol) (2006) 0.95
Lactic acidosis. A presentation of metastatic breast cancer arising in pregnancy. Cancer (1992) 0.95
Predictive assays of radiation response in patients with head and neck squamous cell carcinoma: a review of the Institute Gustave Roussy experience. Int J Radiat Oncol Biol Phys (1997) 0.95
Preliminary study of the treatment of advanced breast cancer in postmenopausal women with the aromatase inhibitor CGS 16949A. Cancer Res (1990) 0.95
Carboplatin: a very active new cisplatin analog in the treatment of small cell lung cancer. Cancer Treat Rep (1985) 0.93
Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma. Cancer Res (1991) 0.93
Three-dimensional kinematic analysis of baseball pitching in acceleration phase. Percept Mot Skills (1995) 0.93
Expression of c-myc oncoprotein represents a new prognostic marker in cutaneous melanoma. Br J Surg (1998) 0.93
Detection of breast carcinoma metastases in bone: relative merits of X-rays and skeletal scintigraphy. Lancet (1983) 0.92
Hemibody irradiation (HBI) for metastatic bone pain in two histologically distinct groups of patients. Clin Oncol (R Coll Radiol) (1989) 0.92
Danazol treatment of advanced breast cancer. Cancer Treat Rep (1981) 0.91
Measurement of S-phase fraction and ploidy in sequential fine-needle aspirates from primary human breast tumours treated with tamoxifen. Br J Cancer (1994) 0.90
The importance of the resection margin in conservative surgery for breast cancer. Eur J Surg Oncol (1996) 0.90
Social and psychological factors in the distribution of STD in male clinic attenders. II Personality disorders, psychiatric illness, and abnormal sexual attitudes. Br J Vener Dis (1983) 0.90
A novel human stress response-related gene with a potential role in induced radioresistance. Radiat Res (1999) 0.89
An assessment of the reliability and reproducibility of measurement of potential doubling times (Tpot) in human colorectal cancers. Br J Cancer (1993) 0.89
Intra-tumoral heterogeneity of tumour potential doubling times (Tpot) in colorectal cancer. Br J Cancer (1993) 0.89
Tests for liver metastases in breast cancer: evaluation of liver scan and liver ultrasound. Clin Oncol (1980) 0.88
Bcl-2 expression in malignant melanoma and its prognostic significance. Eur J Surg Oncol (1996) 0.88
C-myc oncogene expression in human melanoma and its relationship with tumour antigenicity. Eur J Surg Oncol (1996) 0.88
Measurement of c-myc oncoprotein provides an independent prognostic marker for regional metastatic melanoma. Br J Plast Surg (1997) 0.88
Cell kinetics of mouse kidney using bromodeoxyuridine incorporation and flow cytometry: preparation and staining. Cell Tissue Kinet (1987) 0.88
Modulation of the acoustic startle reflex by emotionally-toned film-clips. Int J Psychophysiol (1999) 0.88
The influence of extent and local management on the outcome of radiotherapy for brain metastases. Int J Radiat Oncol Biol Phys (1990) 0.87
Cellular proliferation characteristics do not account for the behaviour of horrifying basal cell carcinoma. A comparison of the growth fraction of horrifying and non horrifying tumours. Br J Plast Surg (1998) 0.87
Extraction of petroleum hydrocarbons from oil-contaminated sediments. Bull Environ Contam Toxicol (1975) 0.87
Combination treatment with tamoxifen and aminoglutethimide in advanced breast cancer. Br Med J (Clin Res Ed) (1983) 0.87
Alterations in dietary carbohydrate, protein, and fat intake and mood state in trained female cyclists. Med Sci Sports Exerc (1991) 0.87
Cell production rates in human tissues and tumours and their significance. Part 1: an introduction to the techniques of measurement and their limitations. Eur J Surg Oncol (2000) 0.86
Stratification of patients by melanoma cell adhesion molecule (MCAM) expression on the basis of risk: implications for sentinel lymph node biopsy. J Plast Reconstr Aesthet Surg (2007) 0.86
Is Dupuytren's disease caused by an imbalance between proliferation and cell death? J Hand Surg Br (1999) 0.86
The prognostic significance of c-myc oncogene expression in uveal melanoma. Melanoma Res (1998) 0.86
Effects of varying concentrations of N2/O2 and He/O2 on exercise tolerance in man. Med Sci Sports Exerc (1980) 0.86
The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer. Br J Cancer (1990) 0.85
Correlation between p53 gene expression and tumor-cell proliferation in oropharyngeal cancer. Int J Cancer (1994) 0.85
15-keto-13,14-dihydroprostaglandin E2 concentrations in serum of patients with breast cancer. Lancet (1977) 0.85
Enhancement of tumor radiosensitivity and reduced hypoxia-dependent binding of a 2-nitroimidazole with normobaric oxygen and carbogen: a therapeutic comparison with skin and kidneys. Int J Radiat Oncol Biol Phys (1992) 0.85
Morbidity of cranial relapse in small cell lung cancer and the impact of radiation therapy. Cancer Treat Rep (1986) 0.85
Low-dose hyper-radiosensitivity is not caused by a failure to recognize DNA double-strand breaks. Radiat Res (2006) 0.85
Predictive value of potential doubling time in head and neck cancer patients treated by conventional radiotherapy. Int J Radiat Oncol Biol Phys (1997) 0.84
The importance of the non-palpable lesion in women under 50, detected by mammography on self-referral for screening, symptoms or follow up. Eur J Surg Oncol (1995) 0.84
The clinical significance of c-myc oncogene expression in melanomas of the scalp. Br J Plast Surg (1998) 0.84
Use of silicone implants after wide local excision of the breast. Br J Surg (1993) 0.84
Screening for metastases in breast cancer: an assessment of biochemical and physical methods. Cancer (1981) 0.84